These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 7823723)

  • 1. Screening blood.
    Rowe PM
    Lancet; 1995 Jan; 345(8944):249. PubMed ID: 7823723
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibody to hepatitis C virus in German blood donors.
    Kühnl P; Seidl S; Stangel W; Beyer J; Sibrowski W; Flik J
    Lancet; 1989 Aug; 2(8658):324. PubMed ID: 2569115
    [No Abstract]   [Full Text] [Related]  

  • 3. Predictive value of anti-HCV reactivity and ALT level.
    Zissis G; Marissens D; Herremans S; de Bruyère M; Lissenko D; Bohy E; Luyasu V
    Acta Clin Belg; 1994; 49(5):251-2. PubMed ID: 7527609
    [No Abstract]   [Full Text] [Related]  

  • 4. [ALAT and viral RNA as risk factors in 68 blood donors with anti-hepatitis C antibodies].
    Tullen E; De Saussure P; Soulier-Lauper M
    Schweiz Med Wochenschr; 1993 Jan; 123(3):57-61. PubMed ID: 7678939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevalence of anti-HCV (C100-3) antibodies in 20.373 blood donors].
    Zufferey C; Lavanchy D; Reiff M; Schneider P; Frei P; Pécoud A; Gonvers JJ
    Schweiz Med Wochenschr; 1992 Oct; 122(41):1524-9. PubMed ID: 1411411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hepatitis C; current developments in diagnosis and therapy].
    Willems M; Moshage H; Fevery J; Yap SH
    Ned Tijdschr Geneeskd; 1992 Dec; 136(52):2564-7. PubMed ID: 1282675
    [No Abstract]   [Full Text] [Related]  

  • 7. National blood requirement, serum ALT and hepatitis in Ethiopian blood donors.
    Zawde D; Sisay Y
    Ethiop Med J; 1991 Oct; 29(4):175-83. PubMed ID: 1659534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevalence of cytomegalovirus, hepatitis B and HIV-1 antibodies in healthy blood donors, hospital patients, kidney transplant recipients, i.v. drug addicts and homosexuals].
    Kägi MK; Joller H; Wunderli W; Rüdlinger R; Joller-Jemelka HI
    Schweiz Med Wochenschr; 1989 Feb; 119(7):217-22. PubMed ID: 2540524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-HIV, anti-HCV, syphilis, HBsAg serologic tests among high-risk groups and blood donors in Yogyakarta, Indonesia.
    Triwibowo
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():275-7. PubMed ID: 7886597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis E in blood donors: investigation of the natural course of asymptomatic infection, Germany, 2011.
    Vollmer T; Diekmann J; Eberhardt M; Knabbe C; Dreier J
    Euro Surveill; 2016 Sep; 21(35):. PubMed ID: 27608433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status of viral hepatitis and HIV transmission in renal transplant recipients: a study in Southeast Asia.
    Sumethkul V; Suchirachato K; Iamsilp V; Pairoj W; Bodhiphala P; Chiewsilp P
    Transplant Proc; 1994 Aug; 26(4):2176-7. PubMed ID: 7520625
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative evaluation and practical importance of instrument-free HIV-1 antibody screening assays.
    Strecker K; Gürtler L; Binibangili M; Metzner-Hoffmann J; Strecker W
    Ann Soc Belg Med Trop; 1991 Sep; 71(3):237-42. PubMed ID: 1958109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Transfusion safety].
    Aprili G
    Haematologica; 1991 Jun; 76 Suppl 3():385-94. PubMed ID: 1752537
    [No Abstract]   [Full Text] [Related]  

  • 14. Performance of Liaison XL automated immunoassay platform for blood-borne infection screening on hepatitis B, hepatitis C, HIV 1/2, HTLV 1/2 and Treponema pallidum serological markers.
    Malm K; Kragsbjerg E; Andersson S
    Transfus Med; 2015 Apr; 25(2):101-5. PubMed ID: 25779614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of donor selection on blood safety in Iran.
    Razjou F; Maghsudlu M; Nasizadeh S; Zadsar M
    Transfus Apher Sci; 2012 Aug; 47(1):13-6. PubMed ID: 22521567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of antibodies to hepatitis C virus in populations at low and high risk for sexually transmitted diseases in Rio de Janeiro.
    Edelenyi-Pinto M; Carvalho AP; Nogueira C; Ferreira Júnior O; Schechter M
    Mem Inst Oswaldo Cruz; 1993; 88(2):305-7. PubMed ID: 7509022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevalence of hepatitis E virus antibodies in blood donors and other population groups in southern Chile].
    Ibarra H; Riedemann S; Reinhardt G; Frieck P; Siegel F; Toledo C; Calvo M; Froösner G
    Rev Med Chil; 1997 Mar; 125(3):275-8. PubMed ID: 9460262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infection with HIV, syphilis and hepatitis B in Ethiopia: a survey in blood donors.
    Rahlenbeck SI; Yohannes G; Molla K; Reifen R; Assefa A
    Int J STD AIDS; 1997 Apr; 8(4):261-4. PubMed ID: 9147161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Significance of hepatitis C virus antibodies in asymptomatic blood donors].
    Zaugg PY; Joller-Jemelka HI; Skruzny Z; Frey-Wettstein M; Bernardi M; Havelka J; Wicki AN; Bühler H
    Schweiz Med Wochenschr; 1995 Apr; 125(15):758-61. PubMed ID: 7537893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and significance of anti-HCV antibodies.
    De Groote J
    Acta Gastroenterol Belg; 1991; 54(3-4):248-56. PubMed ID: 1665270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.